10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,048,651 | -24.0% | 25,422 | -0.0% | 0.05% | -24.6% |
Q1 2023 | $1,379,881 | +48.9% | 25,426 | -0.0% | 0.07% | +60.5% |
Q4 2022 | $926,633 | +28.0% | 25,429 | -0.0% | 0.04% | 0.0% |
Q3 2022 | $724,000 | -37.0% | 25,431 | +0.0% | 0.04% | -35.8% |
Q2 2022 | $1,150,000 | -40.5% | 25,420 | 0.0% | 0.07% | -5.6% |
Q1 2022 | $1,934,000 | -48.9% | 25,420 | 0.0% | 0.07% | -48.6% |
Q4 2021 | $3,787,000 | – | 25,420 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |